[Adrevil improves the peripheral blood flow. Results of a study using the 133-Xe muscle clearance method on lower limbs].
The efficacy of Adrevil has been investigated in 35 patients suffering from arterial blood flow disorders in the lower limb. The patients were given a daily dose of 3 X 2 tablets over a period of 30 days. Changes in muscle perfusion were determined by means of the 133 Xenon muscle clearance. The perfusion volume was found to be increased by 8--12% depending on the severity of the clinical state before treatment. The effect of the drug was more pronounced in cases with severe pathological changes prior to treatment. No adverse reactions were observed.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001775:Blood Circulation / Q000187:drug effects*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006940:Hyperemia / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010069:Oxadiazoles / Q000494:pharmacology*; D014980:Xenon Radioisotopes
D010069:Oxadiazoles; D014980:Xenon Radioisotopes
Adrevil verbessert die periphere Durchblutung. Ergebnisse einer Studie mit der 133-Xe-Muskel-Clearance-Methods an den unteren Extremitäten.